24/7 Market News Snapshot 29 Jul 2024 – Cognition Therapeutics, Inc. Common Stock (NASDAQ: CGTX)

July 29, 2024 6:15

Press Release

DENVER, Colo., 29 July, 2024 (247marketnews.com) – (Nasdaq:CGTX) are discussed in this article.
Cognition Therapeutics, Inc. (CGTX) has been making notable strides, with its common stock experiencing a robust 71.81% surge in the pre-market session, currently trading at $3.455. This uptrend reflects a strong market demand and positive investor sentiment towards the company. In parallel, the company unveiled promising results for its CT1812 treatment, demonstrating an average cognitive improvement of about 40% compared to a placebo, along with consistent positive changes in cognitive and functional measures. The treatment also exhibited a favorable safety profile, with predominantly mild or moderate adverse events reported.

The observed significant changes in Neurofilament Light Chain levels further underscore the treatment’s potential impact in addressing neurodegeneration. To delve deeper into these encouraging outcomes, Cognition Therapeutics, Inc. will be hosting an investor webcast at 8:30 a.m. Eastern Time, offering a comprehensive analysis of the findings. This development signifies a significant advancement in cognitive therapeutics, emphasizing the potential efficacy of CT1812 in enhancing cognitive function. The company’s commitment to pioneering innovative solutions for improving cognitive health and overall quality of life remains unwavering.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.